| Active Not Recruiting | Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy Individuals NCT07493850 | Circul'Egg | Phase 2 |
| Enrolling By Invitation | Evaluation of the Safety and Efficacy of an Injectable Liposomal Gel NCT06997380 | Biovico Sp. z o.o. | N/A |
| Active Not Recruiting | Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling NCT06872359 | Kiomed Pharma | N/A |
| Not Yet Recruiting | Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin NCT06638905 | Goldman, Butterwick, Fitzpatrick and Groff | Phase 2 / Phase 3 |
| Completed | Safety and Efficacy Evaluation of the Monopolar Radiofrequency Device for the Improvement of Facial Wrinkles NCT06657365 | CLASSYS Inc. | N/A |
| Completed | Oral Supplementation With Active Collagen Peptides and Skin Health Improvement NCT06321770 | Gala Servicios Clinicos S.L. | N/A |
| Unknown | A Clinical Study to Evaluate the Efficacy and Satisfaction of RHC Serum Combined With RHC(III) Injection NCT06322875 | DeYi Aesthetic Medical Clinic | N/A |
| Unknown | Histology Study of Biostimulatory Activity of Injectable Poly-L-Lactic Acid (Sculptra Aesthetic) NCT04957446 | Sadick Research Group | N/A |
| Unknown | The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment NCT03836638 | St Joseph University, Beirut, Lebanon | N/A |
| Completed | PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles NCT03774849 | Candela Corporation | N/A |
| Completed | The Use of J-Plasma® for Dermal Resurfacing NCT03286283 | Apyx Medical | N/A |
| Unknown | Evaluation of Safety and Efficacy of TriPollar Device for Treatment of Wrinkles NCT01858415 | Pollogen | N/A |
| Completed | Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles NCT02122536 | YMD Eye and Face | N/A |
| Completed | Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles NCT01566396 | Pollogen | N/A |
| Completed | A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and NCT01447342 | Pacira Pharmaceuticals, Inc | Phase 2 / Phase 3 |
| Completed | Cryo-Touch III Refinement Study Investigational Plan NCT01379365 | Pacira Pharmaceuticals, Inc | Phase 2 / Phase 3 |
| Completed | Cryo-Touch II for the Treatment of Wrinkles NCT01167140 | Pacira Pharmaceuticals, Inc | Phase 2 / Phase 3 |
| Completed | Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adu NCT01124565 | Revance Therapeutics, Inc. | Phase 2 |
| Completed | A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Ad NCT01124552 | Revance Therapeutics, Inc. | Phase 2 |
| Completed | Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers NCT01151436 | Galderma R&D | N/A |
| Completed | Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults NCT01064518 | Revance Therapeutics, Inc. | Phase 2 |
| Completed | Retorna Facial Cream in the Treatment of Facial Wrinkles NCT00978887 | Catalysis SL | Phase 3 |
| Completed | Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines NCT00968942 | Revance Therapeutics, Inc. | Phase 2 |
| Completed | Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines NCT00968825 | Revance Therapeutics, Inc. | Phase 2 |
| Completed | Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI NCT00922623 | Merz North America, Inc. | N/A |
| Completed | Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines NCT00888914 | Revance Therapeutics, Inc. | Phase 2 |
| Withdrawn | Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkl NCT00734786 | Phytotox SA | Phase 1 / Phase 2 |
| Completed | Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft NCT00877279 | Merz North America, Inc. | Phase 3 |
| Completed | A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the N NCT00417469 | Genzyme, a Sanofi Company | Phase 3 |
| Completed | Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®. NCT00876265 | Merz North America, Inc. | Phase 3 |
| Completed | Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds NCT00407914 | Contura | N/A |
| Completed | Evaluation of the Safety and Efficacy of CosmetaLife™ for the Correction of Nasolabial Folds NCT00414544 | Cosmeta | Phase 2 |
| Completed | A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correc NCT00293163 | Genzyme, a Sanofi Company | Phase 4 |
| Completed | A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast. NCT00288470 | Genzyme, a Sanofi Company | N/A |